EHA 2019 | First-line treatment of SAA: towards a new standard of care?

Regis Peffault de Latour

Regis Peffault de Latour, MD, PhD, Saint Louis Hospital, Paris, France, discusses novel combination therapies for the treatment of severe aplastic anemia (SAA). This interview took place at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands.

Share this video